The Attorney General’s lawsuit alleges that Kramer knew about the manufacturing and contamination issues and yet executed a trading plan before those issues were made public in violation of the law.

​Emergent BioSolutions Inc. (NYSE:EBS) is one of the Best Performing Affordable Stocks Under $40. On January 8, Emergent BioSolutions Inc. (NYSE:EBS) announced receiving an order worth up to $21.5 ...

Emergent BioSolutions delivered a strong Q2 2025, beating its own guidance and showing major improvements in margins. EBS has a sound turnaround strategy that is showing signs of success. The company ...

Detailed price information for Reliance Global Group (RELI-Q) from The Globe and Mail including charting and trades.